Page last updated: 2024-09-04

perifosine and imatinib mesylate

perifosine has been researched along with imatinib mesylate in 3 studies

Compound Research Comparison

Studies
(perifosine)
Trials
(perifosine)
Recent Studies (post-2010)
(perifosine)
Studies
(imatinib mesylate)
Trials
(imatinib mesylate)
Recent Studies (post-2010) (imatinib mesylate)
2453114011,4779605,773

Protein Interaction Comparison

ProteinTaxonomyperifosine (IC50)imatinib mesylate (IC50)
Tyrosine-protein kinase ABL1Homo sapiens (human)0.31
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.1

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araujo, DM; Esmaeli, B; Espandar, L; Hatef, E; Kim, SK; Shome, D; Song, CD; Trent, J1
Dogan, SS; Esmaeli, B1
Ho, WL; Wong, H; Yau, T1

Reviews

2 review(s) available for perifosine and imatinib mesylate

ArticleYear
Ocular side effects associated with imatinib mesylate and perifosine for gastrointestinal stromal tumor.
    Hematology/oncology clinics of North America, 2009, Volume: 23, Issue:1

    Topics: Benzamides; Eye Diseases; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Phosphorylcholine; Piperazines; Pyrimidines

2009
The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
    Acta ophthalmologica, 2013, Volume: 91, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bevacizumab; Cetuximab; Crizotinib; Erlotinib Hydrochloride; Eye Diseases; Humans; Imatinib Mesylate; Molecular Targeted Therapy; Neoplasms; Phosphorylcholine; Piperazines; Pyrazoles; Pyridines; Pyrimidines; Quinazolines; Trastuzumab

2013

Trials

1 trial(s) available for perifosine and imatinib mesylate

ArticleYear
Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine.
    Ophthalmology, 2008, Volume: 115, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Corneal Ulcer; Drug Resistance, Neoplasm; Female; Gastrointestinal Stromal Tumors; Glucocorticoids; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Phosphorylcholine; Piperazines; Prednisolone; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies

2008